Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020

JAMA. 2023 Aug 22;330(8):766-3. doi: 10.1001/jama.2023.13628.
No abstract available

Plain language summary

This study assesses the use of mifepristone plus misoprostol for miscarriage management among commercially insured adults in the US.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents, Nonsteroidal* / therapeutic use
  • Abortion, Spontaneous* / drug therapy
  • Female
  • Humans
  • Mifepristone* / therapeutic use
  • Misoprostol
  • Pregnancy


  • Abortifacient Agents, Nonsteroidal
  • Mifepristone
  • Misoprostol